Epigenetic program leading to vessel differentiation

Regenerative medicine has made remarkable progress due to research with embryonic stem (ES) cells and induced pluripotent stem (iPS) cells. However, the mechanism of how blood vessels are constructed from these undifferentiated cells has not yet been clarified. During the creation of new blood vessels, the vascular endothelial growth factor (VEGF) protein differentiates stem cells into vascular endothelial cells and stimulates them to create new blood vessels. Researchers at Kumamoto University added VEGF to undifferentiated ES cells and tracked the behavior of the entire genome and epigenome changes over time in vitro.

Using ES cells developed at Kyoto University's Institute for Frontier Medical Sciences, the research group collected RNA and histones of each cell immediately after VEGF stimulation (0 h), before differentiation (6 h), during differentiation (12 -- 24 h), and after differentiation (48 h). They then comprehensively analyzed the changes in the whole genome and epigenome using next generation deep sequencing.

In the process of blood vessel differentiation, the function of the protein ETS variant 2 (ETV2), which determines the differentiation into vascular endothelium, was first induced within 6 hours of differentiation stimulation. The protein GATA2, which binds to ETV2 and supports vascular endothelial differentiation, was induced immediately thereafter. Transcription factors SOX and FLI1, both important for endothelial differentiation, were induced between 12 and 24 hours. At 48 hours, after differentiation into vascular endothelium was determined, a system of transcription was established in which genes unique to vascular endothelial differentiation were induced.

Furthermore, an examination of the histone code revealed that the regulatory genomic region of the transcription factors (ETS/GATA/SOX) was found to have gradually switched from a "brake histone mark," which suppresses transcription, to an "accelerator histone mark," which activates transcription, while in the process of differentiating into the vascular endothelium. Previously, in the region that controls the function of the transcription factor that promotes differentiation from ES cells to a specific cell type, bivalent modifications of histones such as the accelerator and brake histone marks for transcription were thought to have coexisted.

In addition, when these transcription factors lose their function, terminal differentiation into the vascular endothelium (completion of differentiation) is completely suppressed, and genes that are key to differentiation into vascular endothelial cells as well as transcription factors that maintain the undifferentiated state are adversely induced. Collectively, the transcription factors (ETS/GATA/SOX) not only induce vascular endothelial differentiation, but also suppress regression to an undifferentiated state and differentiation into other ectodermal or endoderm-derived cells.

It is expected that the knowledge of the functions of these transcription factors, when combined with gene editing techniques, will allow for the efficient regeneration of blood vessels.